|
Chidamide + Tislelizumab + chemotherapy (CapeOX ) Clinical Trials
1 actively recruiting trial
No change since May 2026
Pipeline
Phase 2: 1
Top Sponsors
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1
Indications
- Colon Adenocarcinoma1
- Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.